Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

Hepatitis B: FDA Advisers Plug New Drug

September 16, 2002

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

A failed HIV medication should be used to treat the liver-destroying hepatitis B virus, advisers to the US Food and Drug Administration have concluded. If the FDA agrees and makes the use official, Gilead Science's adefovir will become the first new treatment in years for the estimated 1.2 million Americans with the potentially deadly hepatitis infection. Adefovir, originally tested as a potential treatment for AIDS, can be toxic to the kidneys when used at the high doses needed to treat HIV/AIDS. At lower doses adefovir does not cure the chronic infection of hepatitis B, but studies show that liver cirrhosis, as measured by biopsies, improved in 56-66 percent of patients testing the drug, according to Gilead Vice President John Milligan. FDA advisers recommend that all patients get a blood test to check for kidney damage every month or two for as long as they take the drug. Stopping adefovir at the first sign of kidney damage allows most people to recover but the risk proved greater for more advanced hepatitis patients, according to Debra Birnkrant, FDA antiviral drugs chief.

Back to other CDC news for September 16, 2002

Previous Updates

Adapted from:
AIDS Weekly
09.02.02

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Talk to a Physician About HIV/Hepatitis Coinfection in Our "Ask the Experts" Forums
More News and Research on Hepatitis B Prevention and Treatment
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement